PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Liverpool Centre for Cardiovascular Science, University of Liverpool & Liverpool Heart and Chest Hospital, Liverpool, United Kingdom; Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom. Electronic address: stephanie.harrison@liverpool.ac.uk.\', \'Liverpool Centre for Cardiovascular Science, University of Liverpool & Liverpool Heart and Chest Hospital, Liverpool, United Kingdom; Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom.\', \'Liverpool Centre for Cardiovascular Science, University of Liverpool & Liverpool Heart and Chest Hospital, Liverpool, United Kingdom; Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.\', \'TriNetX LLC, London, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1043-6618(21)00118-310.1016/j.phrs.2021.105534
?:doi
?:hasPublicationType
?:journal
  • Pharmacological research
is ?:pmid of
?:pmid
?:pmid
  • 33677103
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.811
?:rankingScore_hIndex
  • 112
is ?:relation_isRelatedTo_publication of
?:title
  • Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all